R E N A T U S

Our mission is to provide safe and effective treatment options for patients living with cholesterol-associated diseases.

 

We primarily focus on developing novel cyclodextrins that can normalize cholesterol homeostasis in our body without serious adverse events.

 

We seek to provide critical impact in developing translational cyclodextrin therapies and fulfill our vision to protect the world from various cholesterol-associate diseases.